ID   HM-1 [Human cervical carcinoma]
AC   CVCL_VI96
DR   Wikidata; Q94212585
RX   PubMed=24723343;
RX   PubMed=28484083;
CC   Population: Chinese; Taiwan.
CC   Doubling time: 35 hours (PubMed=28484083).
CC   Omics: Proteome analysis by 2D-DE/MS.
CC   Derived from site: In situ; Uterus, cervix; UBERON=UBERON_0000002.
ST   Source(s): PubMed=28484083
ST   Amelogenin: X
ST   CSF1PO: 11,12
ST   D13S317: 8,12
ST   D16S539: 10,11
ST   D21S11: 29,32.2
ST   D5S818: 11,12
ST   D7S820: 9,12
ST   TH01: 7,9
ST   TPOX: 8,11
ST   vWA: 14,17
DI   NCIt; C128045; Cervical neuroendocrine carcinoma
DI   ORDO; Orphanet_213777; High-grade neuroendocrine carcinoma of the cervix uteri
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   75Y
CA   Cancer cell line
DT   Created: 07-09-18; Last updated: 29-06-23; Version: 6
//
RX   PubMed=24723343; DOI=10.1002/elps.201400014;
RA   Lin L.-H., Chang S.-J., Hu R.-Y., Lin M.-W., Lin S.-T., Huang S.-H.,
RA   Lyu P.-C., Chou H.-C., Lai Z.-Y., Chuang Y.-J., Chan H.-L.;
RT   "Biomarker discovery for neuroendocrine cervical cancer.";
RL   Electrophoresis 35:2039-2045(2014).
//
RX   PubMed=28484083; DOI=10.18632/oncotarget.17335; PMCID=PMC5542189;
RA   Lai Z.-Y., Yeo H.-Y., Chen Y.-T., Chang K.-M., Chen T.-C., Chuang Y.-J.,
RA   Chang S.-J.;
RT   "PI3K inhibitor enhances the cytotoxic response to etoposide and
RT   cisplatin in a newly established neuroendocrine cervical carcinoma
RT   cell line.";
RL   Oncotarget 8:45323-45334(2017).
//